Phyla

About Phyla

Phyla utilizes bacteriophage technology to target and eliminate pathogenic bacteria responsible for acne and other chronic skin conditions, while preserving beneficial microbiota. Their clinically validated products recalibrate the skin microbiome, offering long-term improvements in skin health without adverse effects.

What does Phyla do?

Phyla utilizes bacteriophage technology to target and eliminate pathogenic bacteria responsible for acne and other chronic skin conditions, while preserving beneficial microbiota. Their clinically validated products recalibrate the skin microbiome, offering long-term improvements in skin health without adverse effects.

When was Phyla founded?

Phyla was founded in 2024.

Founded
2024
Employees
28 employees
Major Investors
Shiseido

Find Investable Startups and Competitors

Search thousands of startups using natural language

Phyla

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

Phyla utilizes bacteriophage technology to target and eliminate pathogenic bacteria responsible for acne and other chronic skin conditions, while preserving beneficial microbiota. Their clinically validated products recalibrate the skin microbiome, offering long-term improvements in skin health without adverse effects.

Funding

Major Investors

Shiseido

Team (25+)

No team information available.
Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.